Lutein and Zeaxanthin: Benefits, Forms, Dosing, and Side Effects

Table of Contents

• Current view (reviewed 26 October 2026)
• Key safety points
• Brad's videos on this topic
• Overview
• Forms and Bioavailability
• Evidence for Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Current view (reviewed 26 October 2026)

For eye health, Brad points to lutein and zeaxanthin as the pair that replaced beta-carotene in AREDS2, and the pair with the trial data behind them (Brad, 19 Aug 2026). In AREDS2, lung cancer occurred in 2.0 per cent of people taking the older beta-carotene formula and 0.9 per cent of those on the newer one, mostly in former smokers, and head to head the lutein and zeaxanthin formula came out ahead on progression of the disease (Brad, 19 Aug 2026). The AREDS2 evidence is in people who already have intermediate AMD or late AMD in one eye, and for healthy adults the case rests on observational data and on trials that raise macular pigment, which is supportive but not definitive (Brad's current guidance, 14 Oct 2026). Raising macular pigment is solid, but Brad calls the brain effect promising, not proven: the cognitive studies are small, and much of the research is funded by the companies that sell the ingredient (Brad, 8 Jul 2026). He offers these as general ideas to discuss with your doctor and notes that he has a commercial interest in this area, so be aware of his potential bias (Brad, 19 Aug 2026). He does not see a role for vitamin A or vitamin E in a multivitamin, given the safety signals in the trials so far (Brad, 19 Aug 2026).

Brad's videos on this topic

• 19 Aug 2026, Multivitamins Are No Longer "Expensive Urine": AREDS2 swapped beta-carotene for lutein and zeaxanthin, lung cancers fell from 2.0 to 0.9 per cent, the new formula came out ahead on disease progression, and Brad names the pair as the eye nutrients with trial data behind them.
• 8 Jul 2026, They Had to Stop This Vitamin C Trial Early: the AREDS2 swap made the eye formula safer and at least as effective; lutein and zeaxanthin reliably raise macular pigment, while the brain effect is promising but not proven.

1. Overview

Lutein and zeaxanthin are xanthophyll carotenoids. With meso-zeaxanthin, they are the three carotenoids the human macula concentrates ^[3]. Lutein and zeaxanthin must come from food, such as green leafy vegetables and orange and yellow fruits and vegetables, while meso-zeaxanthin is rare in the diet and is thought to be formed in the macula from other carotenoids ^[3].

In the macula, high-affinity binding proteins hold these pigments, where they absorb short-wavelength (blue) light and act as antioxidants ^[3]. In post-mortem human tissue, added macular carotenoids quenched singlet oxygen, and a 1:1:1 mix of the three quenched more than any one alone ^[4].

Lutein and zeaxanthin are taken up selectively into eye tissue, and lutein is the main carotenoid in human brain tissue ^[7].

Cohort studies link higher intake with lower risk of late AMD (pooled RR 0.74, 95% CI 0.57 to 0.97) but not early AMD ^[70]. Dietary sources include corn, orange and yellow peppers, eggs and salmon ^[6].

Lutein and zeaxanthin have also been studied for the brain, skin and the eye lens. A 2014 review judged the case for a role in cognition worth further study ^[7]; these non-eye effects rest on less evidence than macular health.

2. Forms and Bioavailability

Free Lutein vs. Lutein Esters

Supplements supply lutein either as free lutein or as lutein esters, in different carrier matrices ^{[10, 13]}. One head-to-head trial compared carriers:

• In a crossover trial in 48 healthy adults, a single 20 mg dose of lutein in a starch-matrix beadlet (FloraGLO) gave a total lutein AUC in the first 72 hours 1.8-fold higher than an alginate-matrix beadlet (Lyc-O-Lutein); both forms were free lutein and both were well tolerated ^[10].

Practical conclusion: The carrier matrix can change how much lutein reaches the blood ^[10].

Meso-Zeaxanthin

Meso-zeaxanthin is formed in the macula and is also sold as a supplement ingredient ^[3]. In a 3-year trial in early AMD, macular pigment rose with all three formulas tested, but only those containing meso-zeaxanthin kept rising between 24 and 36 months ^[12].

Factors Affecting Absorption

Take with fat: In a trial of 8 mg lutein as lutein esters with a hot meal, plasma lutein rose 207% with a high-fat spread (36 g fat) and 88% with a low-fat spread (3 g fat) ^[13]. Taking lutein with food that has some fat makes sense.

Type of fat matters: In lab digestion models, butter and palm oil gave about 20 to 30% higher lutein and zeaxanthin bioaccessibility than olive and fish oils, and rats fed spinach with butter had higher plasma lutein than with olive or fish oil ^[14].

Minerals reduce absorption: In a lab model, calcium, zinc and iron reduced carotenoid micellarization and uptake into intestinal cells, and magnesium reduced uptake only, with iron and zinc having the strongest effects ^[16]. This was a lab study, so the effect in people is uncertain, but taking lutein apart from a large mineral dose may help.

Beta-carotene competition: Taken together, beta-carotene cut the lutein AUC to 54 to 61% of control values, while lutein's effect on beta-carotene varied between people ^[18]. In another study, 15 mg lutein given with 15 mg beta-carotene lowered the beta-carotene response to 66% ^[17].

Dose-response for macular pigment: A 2021 meta-analysis of 46 studies (3,189 participants with healthy eyes) found that 5 to less than 20 mg a day of lutein and zeaxanthin raised macular pigment optical density (MPOD) by 0.04 units (95% CI 0.02 to 0.07), and 20 mg or more raised it by 0.11 units (95% CI 0.06 to 0.16), over 3 to 12 months. Intakes under 5 mg a day showed no significant change ^[19].

Dr Brad Stanfield's MicroVitamin includes Lutein 10 mg and Zeaxanthin 2 mg (as Lutemax 2020), plus Lycopene 10 mg, in its 25-ingredient formula. The lutein and zeaxanthin amounts are the doses used in AREDS2 ^[22]. That trial enrolled people who already had intermediate AMD, or advanced AMD in one eye. In them, lutein and zeaxanthin could be an appropriate substitute for beta-carotene in the AREDS formula, but adding them on top gave no clear overall benefit ^[22]. AREDS2 was not a prevention trial in people without AMD. MicroVitamin is not the AREDS2 formula. It lacks the AREDS formula's high doses of zinc and vitamin C, plus copper, and contains no vitamin E. It is not meant to prevent or treat AMD.

3. Evidence for Benefits

Age-Related Macular Degeneration (AMD)

AMD damages the macula and causes loss of central vision. Lutein and zeaxanthin may protect it by absorbing blue light and acting as antioxidants where light-induced oxidative stress is high ^[3].

Epidemiological Evidence

A 2012 meta-analysis of six cohort studies found that the highest intake of lutein and zeaxanthin was linked to lower risk of late AMD (RR 0.74, 95% CI 0.57 to 0.97) and neovascular AMD (RR 0.68, 95% CI 0.51 to 0.92), but not early AMD (RR 0.96, 95% CI 0.78 to 1.17) ^[70]. In two large US cohorts followed for two decades, the top fifth of predicted plasma lutein and zeaxanthin had lower risk of advanced AMD than the bottom fifth (pooled RR 0.59, 95% CI 0.48 to 0.73), with no link to intermediate AMD ^[71]. In a cohort of 2,037 adults followed for 15 years, those who ate at least one serving of oranges a day had lower odds of late AMD than those who never ate oranges (OR 0.39, 95% CI 0.18 to 0.85); the study looked at flavonoids, not carotenoids ^[20].

AREDS and AREDS2 — Landmark Trials

AREDS (Age-Related Eye Disease Study): This trial did not test lutein or zeaxanthin. It randomised 3,640 people aged 55 to 80 to antioxidants (vitamin C 500 mg, vitamin E 400 IU and beta-carotene 15 mg), zinc 80 mg as zinc oxide with copper 2 mg as cupric oxide, both, or placebo. Over an average of 6.3 years, antioxidants plus zinc reduced the odds of advanced AMD (OR 0.72, 99% CI 0.52 to 0.98) ^[21].

AREDS2 (2013): This trial enrolled 4,203 people aged 50 to 85 at risk of advanced AMD. They were randomised to lutein 10 mg plus zeaxanthin 2 mg, DHA 350 mg plus EPA 650 mg, both, or placebo, on top of the AREDS formula; a secondary randomisation removed beta-carotene, lowered zinc, or both ^[22]. Key findings:

• Adding lutein and zeaxanthin gave no significant reduction in progression to advanced AMD in the primary analysis (HR 0.90, 98.7% CI 0.76 to 1.07) ^[22].
• Adding omega-3 fatty acids gave no benefit (HR 0.97, 98.7% CI 0.82 to 1.16) ^[22]. In the separate VITAL trial, 1 g a day of marine omega-3 fatty acids, with or without vitamin D3, had no significant effect on AMD over a median of 5.3 years (HR 0.94, 95% CI 0.76 to 1.17) ^[23].
• Lutein and zeaxanthin in place of beta-carotene: in exploratory analyses, the direct comparison of lutein and zeaxanthin with beta-carotene gave an HR of 0.82 (95% CI 0.69 to 0.96) for late AMD ^[69]. More lung cancers occurred with beta-carotene than without (23 [2.0%] vs 11 [0.9%]), mostly in former smokers ^[22].
• Lower zinc had no apparent effect on progression ^[22].
• Removing beta-carotene had no apparent effect on progression ^[22].

Long-term AREDS2 follow-up: In 3,882 participants followed for 10 years, lutein and zeaxanthin compared with none gave an HR of 0.91 (95% CI 0.84 to 0.99) for late AMD, and compared directly with beta-carotene an HR of 0.85 (95% CI 0.73 to 0.98). The odds of lung cancer were 1.82 (95% CI 1.06 to 3.12) for those assigned beta-carotene and 1.15 (95% CI 0.79 to 1.66) for lutein and zeaxanthin ^[24]. A post hoc analysis of geographic atrophy (advanced dry AMD) found that in AREDS2 participants not given beta-carotene, lutein and zeaxanthin slowed growth of the atrophy towards the centre of the macula (80.1 vs 114.4 µm a year), though not the growth of its area ^[25].

Clinical Trials with Lutein Supplementation

Richer et al. (2004): In 90 veterans with atrophic AMD, 10 mg of lutein a day, alone or with antioxidants, vitamins and minerals, for 12 months raised macular pigment optical density by about 0.09 log units, and visual acuity improved by 5.4 letters with lutein alone; the placebo group did not change ^[26].

Bartlett and Eperjesi (2007): In a 9-month trial in people with age-related macular disease (10 randomised to placebo, 15 to the active supplement), 6 mg of lutein with vitamins and minerals a day did not improve contrast sensitivity ^[27].

Obana et al. (2015): In 36 healthy Japanese adults taking one of two lutein products for up to 6 months, serum lutein rose but mean macular pigment did not change significantly. People with low macular pigment at baseline responded better ^[28]. Supplementation appears most useful when baseline levels are low.

Korobelnik et al. (2017): In 120 adults whose parents had neovascular AMD, a supplement of lutein, zeaxanthin, omega-3 fatty acids and vitamins for 6 months raised blood lutein and zeaxanthin but did not change macular pigment compared with placebo (difference 0.036, 95% CI -0.037 to 0.110) ^[29].

Akuffo et al. (2015): In 67 people with early AMD, three formulas were compared over 3 years: (1) 20 mg lutein + 0.86 mg zeaxanthin, (2) 10 mg meso-zeaxanthin + 10 mg lutein + 2 mg zeaxanthin, and (3) 17 mg meso-zeaxanthin + 3 mg lutein + 2 mg zeaxanthin. Macular pigment rose from baseline in all groups, with further gains between 24 and 36 months only in the meso-zeaxanthin groups. Visual acuity did not change, and no one progressed to advanced AMD ^[12].

Scott et al. (2025), pistachios and macular pigment: In 36 healthy middle-aged and older adults with low lutein intake and low macular pigment, 2 oz of pistachios a day for 12 weeks raised macular pigment within 6 weeks compared with usual diet, and the gain held at 12 weeks ^[30].

Macular Pigment and Long-Term Supplementation

Macular pigment may keep rising over several years with formulas that include meso-zeaxanthin ^[12]. In healthy eyes, supplementation seems to raise macular pigment mainly when it is low at baseline ^[28].

Goji Berries and Macular Pigment

Goji berry (Lycium barbarum) is rich in zeaxanthin. Two small trials found it raised macular pigment optical density (MPOD):

• Li et al. (2021): In 27 adults aged 45 to 65, 28 g of goji berries five times a week for 90 days raised MPOD, while a supplement with 6 mg lutein and 4 mg zeaxanthin did not ^[31].
• Zhang et al. (2022): In adults with high myopia, 20 g of Lycium barbarum a day (20 mg zeaxanthin and 2 mg lutein) for 3 months gave higher MPOD than 2 mg of lutein ^[32].

Cataracts

Diets rich in lutein and zeaxanthin are linked to less nuclear cataract, though other parts of such diets may explain some of the link ^[34].

Epidemiological evidence: In the Carotenoids in Age-Related Eye Disease Study (CAREDS), women in the highest fifth of dietary lutein and zeaxanthin were 32% less likely to have nuclear cataract than those in the lowest fifth (OR 0.68, 95% CI 0.48 to 0.97) ^[34].

Meta-analyses of observational data: A meta-analysis of blood levels found pooled RRs for nuclear cataract of 0.73 (95% CI 0.59 to 0.87) for lutein and 0.63 (95% CI 0.49 to 0.77) for zeaxanthin. Links with cortical and subcapsular cataract were not statistically significant ^[35].

Interventional evidence (AREDS2): 10 mg lutein with 2 mg zeaxanthin a day had no significant overall effect on progression to cataract surgery (HR 0.96, 95% CI 0.84 to 1.10) over a median of 4.7 years. In the lowest fifth of dietary intake, the HR was 0.68 (95% CI 0.48 to 0.96) ^[36].

Synthesis: Higher lutein and zeaxanthin status is linked to less nuclear cataract, but AREDS2 found no overall benefit from supplements. People with the lowest intake may gain most ^{[34, 35, 36]}.

Retinitis Pigmentosa

In a crossover trial in 34 adults with retinitis pigmentosa, lutein (10 mg a day for 12 weeks, then 30 mg a day) had a significant effect on visual field and might slightly improve visual acuity; the authors advise caution in reading the results ^[37].

Dry Eye Disease

In adults with dry eye disease (77 on the supplement, 78 on placebo), one capsule a day of lutein (20 mg), zeaxanthin isomers (4 mg), curcumin (200 mg curcuminoids) and vitamin D3 (600 IU) for 8 weeks improved tear production and symptom scores compared with placebo. Artificial tear use did not differ between groups ^[38]. This was a combination product, so the effect cannot be credited to lutein alone.

Digital Eye Strain and Screen-Related Symptoms

Stringham et al. (2017): In 48 healthy young adults with at least 6 hours of daily screen time, 24 mg a day of lutein, zeaxanthin and meso-zeaxanthin for 6 months improved macular pigment, sleep quality, headache frequency, eye strain, eye fatigue and visual performance compared with placebo ^[39].

Visual Performance in Healthy Eyes

In 115 healthy young adults, 10 mg lutein plus 2 mg zeaxanthin a day for 1 year raised macular pigment and improved photostress recovery and chromatic contrast compared with placebo. Glare disability did not change significantly ^[40].

Visual Processing Speed

In 69 young healthy adults, two lutein and zeaxanthin supplements taken for 4 months improved macular pigment and visual processing speed, while placebo did not ^[42].

Cognitive Function

Lutein and zeaxanthin collect in brain tissue ^[7], and early trials suggest they may help cognition. Brad's view is that the brain effect is promising, not proven.

Episodic memory (Power et al., 2018): In 91 healthy adults with low macular pigment, 10 mg lutein, 10 mg meso-zeaxanthin and 2 mg zeaxanthin a day for 12 months improved memory scores compared with placebo ^[43].

Cognitive function in young adults (Stringham et al., 2019): In 59 healthy adults aged 18 to 25, 13 mg or 27 mg a day of lutein, zeaxanthin and meso-zeaxanthin for 6 months raised brain-derived neurotrophic factor (BDNF), lowered the inflammatory marker IL-1β, and improved composite memory, verbal memory, sustained attention, psychomotor speed and processing speed compared with placebo ^[47].

Cognitive function in older adults: In 62 older adults (51 analysed), 12 mg a day of lutein plus zeaxanthin improved complex attention and cognitive flexibility compared with placebo, and composite memory in men only ^[45].

Systematic review: A 2021 review of nine brain imaging studies in healthy older adults found that 10 mg of lutein a day for 12 months had positive effects on brain activity and grey matter volume, though the studies drew on similar datasets ^[46].

Psychological Stress

In 59 healthy young adults, 13 mg or 27 mg a day of lutein, zeaxanthin and meso-zeaxanthin improved psychological stress, serum cortisol, and measures of emotional and physical health at 6 months compared with placebo, and these held or improved at 12 months ^[44].

Skin Protection

A small trial suggests these carotenoids may benefit skin.

In a 12-week placebo-controlled trial in 50 healthy adults with dry skin, 10 mg lutein plus 2 mg zeaxanthin isomers a day improved overall skin tone, increased skin lightness, and raised the minimal erythemal dose (the UV exposure needed to cause redness) ^[48].

Cardiovascular Health

A 2016 meta-analysis linked the highest compared with the lowest tertile of lutein intake or blood levels with lower risk of coronary heart disease (pooled RR 0.88, 95% CI 0.80 to 0.98), stroke (pooled RR 0.82, 95% CI 0.72 to 0.93) and metabolic syndrome (pooled RR 0.75, 95% CI 0.60 to 0.92), but not type 2 diabetes ^[49]. In a 3-month trial in 65 people with early atherosclerosis, 20 mg of lutein a day lowered IL-6, MCP-1, LDL cholesterol and triglycerides ^[50]. These are observational links and short-term marker changes, not proof of fewer heart attacks or strokes.

Saffron as a Complementary Ingredient

Saffron (Crocus sativus) contains the antioxidant carotenoids crocin and crocetin ^[51]. It is sometimes added to vision supplements, though neither AREDS formula included it ^{[21, 22]}.

Small studies found that 20 mg of saffron a day improved retinal flicker sensitivity in early AMD ^{[51, 52, 53]}; only the first was placebo-controlled ^[51]. In a crossover trial in 100 adults with mild to moderate AMD, 20 mg of saffron a day for 3 months improved visual acuity by 0.69 letters compared with placebo ^[54].

Propolis

Propolis ("bee glue") is included in some vision products. In lab and mouse studies, Brazilian green propolis protected retinal cells against damage ^[56]. This is lab and animal evidence only.

4. Recommended Dosing

No Established RDA

There is no RDA for lutein or zeaxanthin. A 2021 meta-analysis concluded that the minimum dose and duration needed for a clinically important change in macular pigment still need to be worked out ^[19].

Population-Level Targets

The cohort studies compared the highest with the lowest intake groups and did not set an intake target ^{[70, 71]}.

Clinical Supplementation Doses

For age-related macular degeneration (intermediate AMD, or late AMD in one eye):
AREDS2 used 10 mg lutein + 2 mg zeaxanthin a day, given with an AREDS formula of vitamin C 500 mg, vitamin E 400 IU and zinc with copper; 25 mg zinc was tested against 80 mg ^{[21, 22, 25]}.

For increasing macular pigment optical density:
In the 2021 meta-analysis, under 5 mg a day showed no significant change; 5 to less than 20 mg a day raised MPOD by 0.04 units; 20 mg or more raised it by 0.11 units ^[19].

For retinitis pigmentosa:
10 mg a day for 12 weeks, then 30 mg a day, was used in one small trial ^[37].

For digital eye strain:
24 mg a day of lutein, zeaxanthin and meso-zeaxanthin was used in one 6-month trial ^[39].

Lower Zinc is Sufficient

In AREDS2, lower-dose zinc had no apparent effect on progression to advanced AMD ^[22], and the 10-year follow-up found an HR of 1.04 (95% CI 0.94 to 1.14) for low compared with high zinc ^[24]. The lower dose was 25 mg instead of 80 mg ^[25]. Too much zinc can cause copper deficiency (see Safety section) ^[64].

Blood Level Kinetics

After a single dose, serum lutein peaked at about 16 hours ^[18]. With daily 10 mg lutein plus 2 mg zeaxanthin, serum levels rose by 3 months and stayed raised for the year of the trial ^[40].

Practical Tips

• Take lutein with a meal containing fat ^[13]
• Consider taking it apart from large mineral doses; the evidence is from lab models ^[16]
• If your macular pigment is already high, supplements may add little ^[28]
• Formulas with meso-zeaxanthin kept raising macular pigment into the third year in one trial ^[12]

5. Safety and Side Effects

General Safety

In AREDS2, 10 mg lutein with 2 mg zeaxanthin was taken for a median of 5 years ^[22], and 10-year follow-up found no statistically significant rise in lung cancer with lutein and zeaxanthin ^[24]. In shorter trials, a single 20 mg dose ^[10], 20 mg a day for 8 weeks in a combination product ^[38], and up to 30 mg a day in retinitis pigmentosa ^[37] were well tolerated.

Carotenodermia

Very high carotenoid intakes can turn the skin yellow-orange (carotenodermia). This is generally harmless and fades when intake falls.

Lung Cancer Risk Concern

In a cohort of 77,126 people aged 50 to 76 who recalled their supplement use over the previous 10 years, more than 4 years of individual lutein supplements was linked to higher lung cancer risk (HR 2.02, 95% CI 1.28 to 3.17) ^[63]. The authors advised against long-term lutein supplements to prevent lung cancer, especially in smokers. In AREDS2, the lung cancer excess was with beta-carotene, not lutein and zeaxanthin ^{[22, 24]}.

High-Dose Zinc Risks in Vision Formulas

The original AREDS formula used 80 mg of zinc ^[21]. Zinc products can cause copper deficiency, which can lead to sideroblastic anaemia and neutropenia (a low white cell count) and can mimic other serious blood disorders ^{[64, 73]}.

Case reports describe this even in people taking eye formulas that contain copper ^{[72, 74]}, so people who take high-dose zinc long term should discuss copper monitoring with their doctor. In AREDS2, 25 mg of zinc showed no clear difference from 80 mg in progression (HR 1.04, 95% CI 0.94 to 1.14) ^{[22, 24, 25]}.

6. Drug Interactions

If you take prescription medicines, check with your doctor or pharmacist before starting.

Known Interactions

Beta-carotene: Lutein and beta-carotene compete for absorption. Beta-carotene lowered lutein absorption in one study, and lutein lowered beta-carotene absorption in another ^{[17, 18]}.

Omega-3 fatty acids: AREDS2 gave lutein and zeaxanthin with DHA and EPA in one arm; the combination did not further reduce progression to advanced AMD ^[22].

Mineral supplements: Large amounts of calcium, magnesium, zinc and iron reduced carotenoid uptake in a lab model ^[16].

Saffron (in Combination Products)

Saffron is sometimes included in vision supplements alongside lutein.

Pregnancy and Breastfeeding

Evidence on lutein supplements in pregnancy is sparse: a 2016 review of lutein and cardiometabolic health found only one study in pregnancy ^[49]. If you are pregnant or breastfeeding, ask your doctor first.

7. Dietary Sources

No RDA, But Targets Exist

There is no RDA for lutein or zeaxanthin, and the cohort studies did not set an intake target ^{[70, 71]}.

Richest Food Sources

Green leafy vegetables and orange and yellow fruits and vegetables supply lutein and zeaxanthin ^[3]. Other sources include cantaloupe, pasta, corn, carrots, orange and yellow peppers, fish, salmon and eggs ^[6]. Pistachios are a bioavailable source of lutein ^[30].

Zeaxanthin-Rich Sources

Goji berries are rich in zeaxanthin ^[31]; in one trial, 20 g of Lycium barbarum supplied 20 mg zeaxanthin and 2 mg lutein ^[32]. Daily oranges were linked to lower late AMD risk in one cohort study, which looked at flavonoids ^[20].

Egg Yolks

Eggs are a dietary source of lutein and zeaxanthin ^[6].

Bioavailability from Foods

A 2021 meta-analysis found the effect of dietary sources on macular pigment less clear than that of supplements ^[19]. Pistachios raised macular pigment in people with low intake ^[30].

Practical Recommendations

• Eat dark leafy greens and orange and yellow vegetables often ^[3]
• Daily oranges were linked to lower late AMD risk in one cohort study ^[20]
• Add some fat when eating carotenoid-rich vegetables to help absorption ^[13]
• If your intake is low, food or supplements can raise macular pigment ^{[19, 30]}